| Peer-Reviewed

Mitral Valve Replacement in Senegal (West Africa): Indication and Short-Term Outcomes

Received: 12 December 2017     Accepted: 24 February 2018     Published: 10 April 2018
Views:       Downloads:
Abstract

The West African countries have infrequent Cardiac Surgery Centers. Mitral valve replacement (MVR) from such countries raises important postoperative preoccupations. The aim of this study is to report indication and short-term outcomes of MVR at the Cardiac Surgery Center of the University Hospital in Dakar (Senegal). This is a retrospective analytical and descriptive study covering a period of 19 months (From January 2015 to July 2016). All patients with MVR associated or not with tricuspid valve repair were included in this study. Seventy-three (73) patients were eligible. The mean follow-up was 4.2 ± 4 months (range, 1-12). The mean age was 30.4 ± 13 years (range, 9–64). There were 74% of female patients, 53% were in New York Heart Association class III. Preoperative diagnoses were mitral stenosis (31.5%); mitral regurgitation (37%) and mixed mitral disease (31.5%). Crystalloid cardioplegia was performed in 92%, mean CPB time was 79 ± 21 min, mean cross clamp time was 58 ± 15.6 min. Mitral valve exposure was performed by left atriotomy (93%); 99% of mechanical prosthesis was performed. Tricuspid valve repair was performed concomitantly in 48% of patients. Overall Hospital mortality was 8%. Postoperative complications were low output syndrome (19%), pneumonia (12%), surgical wound infection (8%), Pleural effusion (7%). During follow-up, no valve-related morbidity and mortality was recorded. Mechanical valve replacement in Senegal has acceptable early outcomes in terms of morbi-mortality. Preoperative diagnoses were represented in equivalent proportions by mitral stenosis; mitral regurgitation and mixed mitral disease. Our complications were predominantly low output syndrome and pleura pulmonary disorders.

Published in Cardiology and Cardiovascular Research (Volume 2, Issue 1)
DOI 10.11648/j.ccr.20180201.14
Page(s) 15-18
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2018. Published by Science Publishing Group

Keywords

Cardiac Surgery, Mitral Valve Replacement, West Africa, Outcomes

References
[1] Kingué S, Ba SA, Balde D, Diarra MB, Anzouan-Kacou JB, Anisubia B, Damorou JM, Ndobo P, et al. The Valvafric study: A registry of rheumatic heart disease in Western and Central Africa. Arch Cardiovasc Dis. 2016; 109 (5):321-9.
[2] Balaka A, Tchamdja T, Djibril MA, Djagadou KA, Tchandana M, Damorou F, Agbétra A. Valvular heart disease in hospitals in Lome (Togo). Pan Afr Med J. 2015; 20:168.
[3] Zilla P, Koshy J, Brink J, Human P. Mitral valve replacement for rheumatic heart disease in Southern Africa. Journal of Cardiothoracic Surgery. 2013; 8 (Suppl 1):O294. doi:10.1186/1749-8090-8-S1-O294.
[4] Leguerrier A, Flecher E, Fouquet O, Lelong B. Prothèses valvulaires cardiaques. EMC – Cardiologie. 2009; 30:1-31.
[5] Nwiloh JO, Oludara MA, Adebola PA, Edaigbini, SA, Danbauchi S, Sowunmi AC. Experience with prosthetic valve replacement in indigents with rheumatic heart disease in Nigeria: 10-Year Follow-Up. World J Cardiovasc Surg. 2015; 5 (08):75.
[6] Yangni-Angate KH, Meneas C, Diby F, Diomande M, Adoubi A, Tanauh Y. Cardiac surgery in Africa: a thirty-five-year experience on open heart surgery in Cote d'Ivoire. Cardiovasc Diagn Ther. 2016; 6 (1):44-63.
[7] Edwin F, Aniteye E, Tettey MM, Tamatey M, Frimpong-Boateng K. Outcome of left heart mechanical valve replacement in West African children - a 15-year retrospective study. J Cardiothorac Surg. 2011; 6:57.
[8] Samiei N, Hakimi MR, Mirmesdagh Y, Peighambari MM, Alizadeh-Ghavidel A, Hosseini S. Surgical outcomes of heart valves replacement: A study of tertiary specialied cardiac center. ARYA Atherosclerosis. 2014; 10 (5):233-237.
[9] Bourguignon T, Bergöend E, Mirza A, Ayegnon G, Neville P, Aupart MR, Marchand M. Risk factors for valve-related complications after mechanical heart valve replacement in 505 patients with long-term follow up. J Heart Valve Dis. 2011; 20 (6):673-80.
[10] Mvondo CM, Pugliese M, Giamberti A, Chelo D, Kuate LM, Boombhi J, Dailor EM. Surgery for rheumatic mitral valve disease in sub-saharan African countries: why valve repair is still the best surgical option. Pan Afr Med J. 2016; 24:307.
[11] Zouaoui W, Ouldzein H, Drissa MA, Essafi N, Meddeb I, Drissa H. [Short- and long-term results of mitral valve replacement by caged-ball and bileaflet mechanical prosthesis (series of 236 consecutive patients with average follow-up of 11 years)]. Ann Cardiol Angeiol. 2009; 58 (2):86-93.
[12] Benedetto U, Melina G, Angeloni E, Refice S, Roscitano A, Comito C, Sinatra R. Prophylactic tricuspid annuloplasty in patients with dilated tricuspid annulus undergoing mitral valve surgery. J of Thorac and Cardiovasc Surg. 2012; 143 (3): 632-638.
[13] Rezahosseini O, Rezaei M, Ahmadi Tafti SH, Jalali A, Bina P, Ghiasi A, Karimi A, Abbasi K, Shirzad M, Davoodi S, Salehi Omran A. Transseptal Approach versus Left Atrial Approach to Mitral Valve: A Propensity Score Matching Study. J Tehran Heart Cent. 2015; 10 (4):188-93.
[14] Al Mosa AF, Omair A, Arifi AA, Najm HK. Mitral valve replacement for mitral stenosis: A 15-year single center experience. J Saudi Heart Assoc. 2016; 28 (4):232-8.
[15] Takano H, Hiramatsu M, Kida H, Uenoyama M, Horiguchi K, Yamauchi T, Kin K, Shirakawa Y, Kaneko M, Daimon T. Severe tricuspid regurgitation after mitral valve surgery: the risk factors and results of the aggressive application of prophylactic tricuspid valve repair. Surg Today. 2017; 47 (4):445-456.
Cite This Article
  • APA Style

    Abdel-Kémal Bori Bata, Amadou Gabriel Ciss, Momar Sokhna Diop, Papa Salmane Ba, Diagne Papa Amath, et al. (2018). Mitral Valve Replacement in Senegal (West Africa): Indication and Short-Term Outcomes. Cardiology and Cardiovascular Research, 2(1), 15-18. https://doi.org/10.11648/j.ccr.20180201.14

    Copy | Download

    ACS Style

    Abdel-Kémal Bori Bata; Amadou Gabriel Ciss; Momar Sokhna Diop; Papa Salmane Ba; Diagne Papa Amath, et al. Mitral Valve Replacement in Senegal (West Africa): Indication and Short-Term Outcomes. Cardiol. Cardiovasc. Res. 2018, 2(1), 15-18. doi: 10.11648/j.ccr.20180201.14

    Copy | Download

    AMA Style

    Abdel-Kémal Bori Bata, Amadou Gabriel Ciss, Momar Sokhna Diop, Papa Salmane Ba, Diagne Papa Amath, et al. Mitral Valve Replacement in Senegal (West Africa): Indication and Short-Term Outcomes. Cardiol Cardiovasc Res. 2018;2(1):15-18. doi: 10.11648/j.ccr.20180201.14

    Copy | Download

  • @article{10.11648/j.ccr.20180201.14,
      author = {Abdel-Kémal Bori Bata and Amadou Gabriel Ciss and Momar Sokhna Diop and Papa Salmane Ba and Diagne Papa Amath and Ndeye Fatou Sow and Gaye Magaye and Souleyman Diatta and Mohamed Leye and Etienne Birame Sene and Papa Adama Dieng and Salimata Diallo and Assane Ndiaye and Mouhamadou Ndiaye},
      title = {Mitral Valve Replacement in Senegal (West Africa): Indication and Short-Term Outcomes},
      journal = {Cardiology and Cardiovascular Research},
      volume = {2},
      number = {1},
      pages = {15-18},
      doi = {10.11648/j.ccr.20180201.14},
      url = {https://doi.org/10.11648/j.ccr.20180201.14},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ccr.20180201.14},
      abstract = {The West African countries have infrequent Cardiac Surgery Centers. Mitral valve replacement (MVR) from such countries raises important postoperative preoccupations. The aim of this study is to report indication and short-term outcomes of MVR at the Cardiac Surgery Center of the University Hospital in Dakar (Senegal). This is a retrospective analytical and descriptive study covering a period of 19 months (From January 2015 to July 2016). All patients with MVR associated or not with tricuspid valve repair were included in this study. Seventy-three (73) patients were eligible. The mean follow-up was 4.2 ± 4 months (range, 1-12). The mean age was 30.4 ± 13 years (range, 9–64). There were 74% of female patients, 53% were in New York Heart Association class III. Preoperative diagnoses were mitral stenosis (31.5%); mitral regurgitation (37%) and mixed mitral disease (31.5%). Crystalloid cardioplegia was performed in 92%, mean CPB time was 79 ± 21 min, mean cross clamp time was 58 ± 15.6 min. Mitral valve exposure was performed by left atriotomy (93%); 99% of mechanical prosthesis was performed. Tricuspid valve repair was performed concomitantly in 48% of patients. Overall Hospital mortality was 8%. Postoperative complications were low output syndrome (19%), pneumonia (12%), surgical wound infection (8%), Pleural effusion (7%). During follow-up, no valve-related morbidity and mortality was recorded. Mechanical valve replacement in Senegal has acceptable early outcomes in terms of morbi-mortality. Preoperative diagnoses were represented in equivalent proportions by mitral stenosis; mitral regurgitation and mixed mitral disease. Our complications were predominantly low output syndrome and pleura pulmonary disorders.},
     year = {2018}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Mitral Valve Replacement in Senegal (West Africa): Indication and Short-Term Outcomes
    AU  - Abdel-Kémal Bori Bata
    AU  - Amadou Gabriel Ciss
    AU  - Momar Sokhna Diop
    AU  - Papa Salmane Ba
    AU  - Diagne Papa Amath
    AU  - Ndeye Fatou Sow
    AU  - Gaye Magaye
    AU  - Souleyman Diatta
    AU  - Mohamed Leye
    AU  - Etienne Birame Sene
    AU  - Papa Adama Dieng
    AU  - Salimata Diallo
    AU  - Assane Ndiaye
    AU  - Mouhamadou Ndiaye
    Y1  - 2018/04/10
    PY  - 2018
    N1  - https://doi.org/10.11648/j.ccr.20180201.14
    DO  - 10.11648/j.ccr.20180201.14
    T2  - Cardiology and Cardiovascular Research
    JF  - Cardiology and Cardiovascular Research
    JO  - Cardiology and Cardiovascular Research
    SP  - 15
    EP  - 18
    PB  - Science Publishing Group
    SN  - 2578-8914
    UR  - https://doi.org/10.11648/j.ccr.20180201.14
    AB  - The West African countries have infrequent Cardiac Surgery Centers. Mitral valve replacement (MVR) from such countries raises important postoperative preoccupations. The aim of this study is to report indication and short-term outcomes of MVR at the Cardiac Surgery Center of the University Hospital in Dakar (Senegal). This is a retrospective analytical and descriptive study covering a period of 19 months (From January 2015 to July 2016). All patients with MVR associated or not with tricuspid valve repair were included in this study. Seventy-three (73) patients were eligible. The mean follow-up was 4.2 ± 4 months (range, 1-12). The mean age was 30.4 ± 13 years (range, 9–64). There were 74% of female patients, 53% were in New York Heart Association class III. Preoperative diagnoses were mitral stenosis (31.5%); mitral regurgitation (37%) and mixed mitral disease (31.5%). Crystalloid cardioplegia was performed in 92%, mean CPB time was 79 ± 21 min, mean cross clamp time was 58 ± 15.6 min. Mitral valve exposure was performed by left atriotomy (93%); 99% of mechanical prosthesis was performed. Tricuspid valve repair was performed concomitantly in 48% of patients. Overall Hospital mortality was 8%. Postoperative complications were low output syndrome (19%), pneumonia (12%), surgical wound infection (8%), Pleural effusion (7%). During follow-up, no valve-related morbidity and mortality was recorded. Mechanical valve replacement in Senegal has acceptable early outcomes in terms of morbi-mortality. Preoperative diagnoses were represented in equivalent proportions by mitral stenosis; mitral regurgitation and mixed mitral disease. Our complications were predominantly low output syndrome and pleura pulmonary disorders.
    VL  - 2
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal

  • Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal

  • Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal

  • Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal

  • Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal

  • Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal

  • Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal

  • Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal

  • Department of Cardiology FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal

  • Department of Anesthesiology FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal

  • Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal

  • Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal

  • Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal

  • Department of Thoracic and Cardiovascular Surgery FANN University Hospital, Cheikh Anta Diop University, Dakar, Senegal

  • Sections